Latest Hormone replacement therapy Stories
The Firm is evaluating potential testosterone treatment lawsuits on behalf of men who allegedly experienced heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening
NORTHRIDGE, Calif., Oct.
Increased patient demand for natural hormone therapy drives growth of national physician training program SCOTTSDALE, Ariz., Oct.
Eli Lilly failed to warn that the testosterone replacement drug, Axiron, may increase the risk of heart attack and stroke, a lawsuit filed in federal court alleges.
As Testosterone Complaints Continue to Increase, the FDA Furthers Its Investigation into Testosterone Use by Holding a Meeting of Its Advisory Panels to Explore the Safety and Effectiveness of
FDA Reviewing the Safety of AndroGel and Other Approved Low Testosterone Treatments after Studies Linked Their Use to a Higher Risk of Heart Attacks, Strokes and Death in Certain Men
Natural Hormone Replacement Pioneer Cites Bad Research; Recommends Expanding Research to Include Bio-Identical Therapy DALLAS, Oct. 2, 2014 /PRNewswire/ -- Dr.
Experienced lawyers review the increase in testosterone lawsuits after the FDA advisory panel’s caution against the over-prescription of testosterone therapy drugs. Kansas
MANSFIELD, Texas, Sept. 29, 2014 /PRNewswire/ -- HerKare opens a new location today in Mansfield, Texas. This marks HerKare's third center in Dallas-Fort Worth.
FDA Advisors Also Recommended That Manufacturers of Testosterone Treatments Conduct Studies of Their Potential Heart Risks Chicago IL (PRWEB) September 23, 2014
- Having no light.